MedPath

CanWell Biotech Limited

🇭🇰Hong Kong, China
Ownership
-
Employees
-
Market Cap
-
Website

CAN1012 Combined With PD-1 in Patients With Solid Tumors

Phase 1
Recruiting
Conditions
Advanced Solid Tumor
Interventions
First Posted Date
2024-05-13
Last Posted Date
2024-10-31
Lead Sponsor
Canwell Biotech Limited
Target Recruit Count
71
Registration Number
NCT06410703
Locations
🇨🇳

Sun Yat-Sen University Sun Yat-Sen Memorial Hospital, Guangzhou, Guangdong, China

Intratumoral CAN2109 in Subjects With Solid Tumors

Phase 1
Recruiting
Conditions
Lymphoma
Solid Tumor
Interventions
First Posted Date
2024-03-27
Last Posted Date
2024-12-19
Lead Sponsor
Canwell Biotech Limited
Target Recruit Count
27
Registration Number
NCT06332430
Locations
🇨🇳

Sun Yat-Sen University Sun Yat-Sen Memorial Hospital, Guangzhou, Guangdong, China

Intratumoral CAN1012(selective TLR7 Agonist) in Subjects with Solid Tumors

Phase 1
Active, not recruiting
Conditions
Solid Tumor
Interventions
First Posted Date
2022-10-14
Last Posted Date
2025-02-13
Lead Sponsor
Canwell Biotech Limited
Target Recruit Count
27
Registration Number
NCT05580991
Locations
🇨🇳

Canwell Biotech Limited, Guangzhou, Guangdong, China

© Copyright 2025. All Rights Reserved by MedPath